INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,320 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Grant or award
A—
6,586 sh
Feb 9, 2026Feb 11, 2026
Page 1290 of 1758
← PrevNext →
traded Feb 9, 2026
+2d
SEC Form 4

Evidence

5
GP
Gupta PriyaInterim CFO
ACHRArcher Aviation Inc.
Grant or award
A—
123.5K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Grant or award
A—
185.2K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
SM
Stasiowska Ewa MariaChief Risk Officer
LOBLive Oak Bancshares, Inc.
Grant or award
A—
8,383 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Grant or award
A—
9,219 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$492K
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Grant or award
A—
21.7K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Option exercise
M—
19.6K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Disposition to issuer
D—
19.6K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Tax withholding
F$29K
709 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

5
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Grant or award
A—
8,938 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Grant or award
A—
50.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

5
YH
Yang HongyongVP and GM Fuel Syst. Asia Pac
PHINPHINIA INC.
Grant or award
A—
1,197 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Option exercise
M—
19.6K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Grant or award
A—
1,100 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

5
LA
Landry Stephen AlanSVP, Chief Operations Officer
THSTreeHouse Foods, Inc.
Disposition to issuer
D—
21.7K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

5
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Grant or award
A—
1,550 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$59K
75 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$113K
144 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

3
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
2,756 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
1,076 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
2,500 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$42K
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
AE
Apostolides James EChief Infra & Performance Ofcr
BKRBaker Hughes Co
Option exercise · 10b5-1 plan
M—
11.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
2,471 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
2,958 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
567 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

0
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M—
8,374 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
2,520 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence